http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016201861-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23a4e0c875bf1ac2b8a3b76517de6c7d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2197ed124d3a235ebbaf4c0ed4cc7aec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a204e7a979412d9392bedcca5cbaae6b |
| publicationDate | 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2016201861-B2 |
| titleOfInvention | Cell-permeant peptide-based inhibitor of kinases |
| abstract | CELL-PERMEANT PEPTIDE-BASED INHIBITOR OF KINASES The described invention provides kinase inhibiting compositions containing a therapeutic amount of a therapeutic inhibitor peptide that inhibits at least one kinase enzyme, methods for treating an inflammatory disorder whose pathophysiology comprises inflammatory cytokine expression, and methods for treating an inflammatory disorder whose pathophysiology comprises inflammatory cytokine expression using the kinase inhibiting compositions. |
| priorityDate | 2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 545.